Are you Dr. Munhoz?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 1 invite waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
504 E 63rd St
Ap 6o
New York, NY 10065Phone+1 929-262-9067- Is this information wrong?
Summary
- Dr. Rodrigo Munhoz, MD is a hematologist in New York, New York.
Clinical Trials
- Nivolumab in Patients With Advanced Cutaneous Squamous Cell Carcinoma Start of enrollment: 2019 Sep 05
Publications & Presentations
PubMed
- 4 citationsCombinatorial Approaches to the Treatment of Advanced Melanoma.Rodrigo Ramella Munhoz, Michael A. Postow> ;Hematology/oncology Clinics of North America. 2021 Feb 1
- 3 citationsMerkel cell carcinoma in Latin America: a contribution from an expanded access program for avelumab to address issues from experts’ recommendationsRodrigo Ramella Munhoz, Federico Cayol, Luis Corrales, Raquel Gerson, Malena Tilli, Elluz Oliver Barreto, Jesús Oswaldo Sánchez Castillo, Rafael Schmerling, Gabriela C...> ;Cancer Immunology, Immunotherapy. 2021 Apr 1
- 2 citationsSurgical resection, intraoperative radiotherapy and immediate plastic reconstruction: A good option for the treatment of distal extremity soft tissue sarcomas.Samir Abdallah Hanna, Rodrigo Ramella Munhoz, André Luis de Freitas Perina, Marina Sahade Goncalves, Fabio Paganini Pereira da Costa, Fabio de Freitas Busnardo, Fabio ...> ;Reports of Practical Oncology and Radiotherapy. 2020 Oct 3
- Join now to see all
Press Mentions
Nivolumab Promising for Treatment of Advanced Cutaneous SCCOctober 26th, 2022- Promising Immunotherapy Drug May Soon Become Standard Treatment for Skin CancerOctober 26th, 2022
- Phase II Clinical Trial Generates Promising Results for Immunotherapy Drug Nivolumab in Patients with Advanced Skin CancerOctober 24th, 2022
- Join now to see all
